CDC, FDA looking into risk of rare nerve complication after Johnson & Johnson Covid-19 vaccine
CNN
Federal health officials are investigating the possibility that Johnson & Johnson's coronavirus vaccine might slightly raise the risk of a rare neurological complication known as Guillain-Barré syndrome, a spokesperson from CDC tp;d CNN Monday.
A spokesperson for the US Centers for Disease Control and Prevention told CNN on Monday the agency had seen preliminary reports about 100 cases of Guillain-Barré syndrome out of about 12.8 million vaccinations given. Johnson & Johnson confirmed it was talking to the CDC and FDA about the issue.More Related News
Tulsi Gabbard, Donald Trump’s pick to lead the intelligence community, was briefly placed on a Transportation Security Administration list that prompts additional security screening before flights after her overseas travel patterns and foreign connections triggered a government algorithm earlier this year, three sources familiar with the matter told CNN.